News ArticleFortis Healthcare Limited Posts Rs 17,769 Lakh Net Profit in H1 FY2026-27 with Rs 100,886 Lakh Revenue
Company reports Rs 12,991 lakh net profit for Q2 ending September 30, 2026, discloses ongoing SFIO investigations and Supreme Court-ordered forensic audit
Fortis Healthcare Limited announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026, reporting a net profit of Rs 12,991 lakh for Q2 and Rs 17,769 lakh for H1 FY2026-27, supported by Rs 100,886 lakh revenues for H1. The results include an exceptional gain and ongoing legal and regulatory investigations disclosure.
Fortis Healthcare Limited
Financial Results
Fortis Healthcare Limited released its unaudited standalone financial results for the quarter and half year ended September 30, 2026, showing a net profit of Rs 12,991 lakh for the quarter and Rs 17,769 lakh for the half year, on operating revenues totaling Rs 100,886 lakh for H1 FY2026-27.
The company reported total income of Rs 111,928 lakh for H1, including Rs 100,886 lakh from operations and Rs 11,042 lakh from other income.
Total expenses for the half year amounted to Rs 93,442 lakh, covering medical consumables, employee benefits, finance costs, doctor consultation fees, depreciation, and other expenses.
An exceptional gain of Rs 2,036 lakh was recorded during the half year period.
Fortis Healthcare disclosed ongoing investigations by the Serious Fraud Investigation Office (SFIO) into alleged improper transactions and compliance issues dating to before the current board's control in 2018.
Additionally, the Supreme Court directed a forensic audit of certain transactions, with the High Court of Delhi appointing forensic auditors in August 2026 as part of the inquiry process.
Highlights
- Stand-alone net profit for Q2 FY2026-27: Rs 12,991 lakh
- Half year net profit: Rs 17,769 lakh
- Revenue from operations for six months: Rs 100,886 lakh
- Exceptional gain recorded: Rs 2,036 lakh
- SFIO investigation ongoing regarding past transactions prior to 2018 takeover
- Supreme Court and High Court directed forensic audit on related-party transactions with RHT Health Trust
Key Data Snapshot
What happened
- Fortis Healthcare Limited approved unaudited standalone financial results for Q2 and H1 FY2026-27 on November 5, 2026.
- The company posted Rs 12,991 lakh net profit for Q2 and Rs 17,769 lakh net profit for the half year ended September 30, 2026.
- Total revenues for the half year amounted to Rs 100,886 lakh from operations and Rs 11,042 lakh from other income.
Key details
- Expenses for the half year included medical consumables, employee benefits, finance costs, consultation fees, depreciation, and other expenses totaling Rs 93,442 lakh.
- An exceptional gain of Rs 2,036 lakh was captured in the reporting period.
- The results are unaudited but subject to limited review by the statutory auditor BS R & Co. LLP.
Regulatory and governance context
- Ongoing investigation by the Serious Fraud Investigation Office (SFIO) concerns alleged improper transactions and legal non-compliances prior to 2018.
- The Supreme Court on September 22, 2022, ordered the Delhi High Court to consider appointing forensic auditors for transactions with RHT Health Trust and related matters.
- The Delhi High Court appointed forensic auditors in August 2026 to examine these transactions as directed by the Supreme Court.
Highlights
- Stand-alone net profit for Q2 FY2026-27: Rs 12,991 lakh
- Half year net profit: Rs 17,769 lakh
- Revenue from operations for six months: Rs 100,886 lakh
- Exceptional gain recorded: Rs 2,036 lakh
- SFIO investigation ongoing regarding past transactions prior to 2018 takeover
- Supreme Court and High Court directed forensic audit on related-party transactions with RHT Health Trust
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure includes transactions with RHT Health Trust subject to forensic audit.
Issues relate to alleged improper transactions and non-compliances prior to takeover by the current board in 2018, involving erstwhile promoters and their related entities.
Source Information
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Sansera Engineering Posts Rs 1,092.53 Million Profit in Q2 2026 After US$2 Million Lawsuit Settlement
Sansera Engineering Limited announced unaudited standalone results for Q2 and half year ended September 30, 2026, registering a net profit of Rs 1,092.53 million for the quarter and Rs 1,959.30 million for six months. The company settled a United States civil lawsuit by paying US$2 million during this period, recognized as an exceptional expense.
Read Full Story
Godfrey Phillips India Announces Q2 FY2027 Financial Results and Rs. 10 Per Share Interim Dividend
Godfrey Phillips India Limited approved its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The company declared an interim dividend of 500% or Rs. 10 per equity share of Rs. 2 each for the fiscal year ending March 31, 2027.
Read Full Story
Rubicon Research Limited Reports ₹1,430.69 Million Net Profit for Half Year Ended September 30, 2026
Rubicon Research Limited announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026, reporting a net profit after tax of ₹1,430.69 million for the six-month period.
Read Full Story
